UnitedHealth Group Incorporated (NYSE:UNH) Stake Raised by RMR Wealth Builders

by · The Cerbat Gem

RMR Wealth Builders boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 19.1% in the 4th quarter, Holdings Channel reports. The firm owned 4,034 shares of the healthcare conglomerate’s stock after buying an additional 647 shares during the period. RMR Wealth Builders’ holdings in UnitedHealth Group were worth $2,040,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Lone Pine Capital LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $480,903,000. Dimensional Fund Advisors LP boosted its stake in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Accredited Investors Inc. boosted its position in shares of UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after buying an additional 776,516 shares during the period. Finally, Raymond James & Associates lifted its stake in UnitedHealth Group by 33.1% in the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after acquiring an additional 587,088 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $4.41 during trading hours on Friday, reaching $520.11. The stock had a trading volume of 5,454,731 shares, compared to its average volume of 4,179,457. The company has a market cap of $478.65 billion, a price-to-earnings ratio of 33.88, a PEG ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The business’s fifty day moving average is $556.20 and its two-hundred day moving average is $561.20. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the business posted $6.56 earnings per share. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on UNH. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday. Finally, UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $626.79.

Get Our Latest Analysis on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).